Sandeep Laumas, Executive Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 3,000 shares at $2.64 ($8K) on 2018-11-30, disclosed to the SEC on 2018-12-03.
Open-market purchase of $8k INNT by Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.62 | 1,000 | $3K | 33.2% |
| 2 | $2.63 | 1,000 | $3K | 33.3% |
| 3 | $2.64 | 1,000 | $3K | 33.5% |
| Total | $2.63 avg | 3,000 | $8K | 100% |
| Filing → |
| INNT | BUY | 2019-06-17 | $1K | — | Filing → |
| INNT | BUY | 2019-05-23 | $7K | — | Filing → |
| INNT | BUY | 2018-11-29 | $8K | — | Filing → |